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Type 1 diabetes (T1D) is a genetically complex disorder of glucose homeostasis that results from the autoimmune
destruction of the insulin-secreting cells of the pancreas. Two previous whole-genome scans for linkage to T1D in
187 and 356 families containing affected sib pairs (ASPs) yielded apparently conflicting results, despite partial
overlap in the families analyzed. However, each of these studies individually lacked power to detect loci with locus-
specific disease prevalence/sib-risk ratios (ls) !1.4. In the present study, a third genome scan was performed using
a new collection of 225 multiplex families with T1D, and the data from all three of these genome scans were
merged and analyzed jointly. The combined sample of 831 ASPs, all with both parents genotyped, provided 90%
power to detect linkage for loci with ls p 1.3 at . Three chromosome regions were identified that
54Pp 7.4 # 10
showed significant evidence of linkage ( ; LOD scores 14), 6p21 (IDDM1), 11p15 (IDDM2), 16q22-55P ! 2.2 # 10
q24, and four more that showed suggestive evidence ( , LOD scores 2.2), 10p11 (IDDM10), 2q3154P ! 7.4 # 10
(IDDM7, IDDM12, and IDDM13), 6q21 (IDDM15), and 1q42. Exploratory analyses, taking into account the
presence of specific high-risk HLA genotypes or affected sibs’ ages at disease onset, provided evidence of linkage
at several additional sites, including the putative IDDM8 locus on chromosome 6q27. Our results indicate that
much of the difficulty in mapping T1D susceptibility genes results from inadequate sample sizes, and the results
point to the value of future international collaborations to assemble and analyze much larger data sets for linkage
in complex diseases.
Introduction
Type 1 diabetes (T1D [MIM 222100]) is characterized
by autoimmune destruction of pancreatic b cells and a
subsequent complete dependence on exogenously ad-
ministered insulin for the regulation of blood glucose
levels. The increased concordance rates for T1D in iden-
tical twins and the tendency for the disorder to aggregate
within families suggest that at least some portion of sus-
ceptibility to T1D is genetically determined. However,
within families, the disorder follows no clear mode of
inheritance and is generally thought to result from the
combined effects of multiple genes interacting with non-
genetic factors (Risch 1987; Thomson et al. 1988; Rich
1990).
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T1D has a long history of studies evaluating candi-
date genes for allelic association with disease status in
either family-based or case-control formats. Two chro-
mosomal regions have emerged from these studies, with
consistent and significant evidence of association with
T1D across multiple reports. The first is the HLA region
at 6p21.3 (IDDM1). HLA-DQB1 (MIM 604305) and
HLA-DRB1 (MIM 142857) are the major components
of IDDM1, with at least two other loci involved, in-
cluding HLA-DPB1 (MIM 142858) (Todd et al. 1987;
Horn et al. 1988; Easteal et al. 1990; Erlich et al. 1996;
Lie et al. 1999; Noble et al. 2000; Cucca et al. 2001).
The second chromosome region that displays consis-
tent evidence of allelic association with T1D is the in-
sulin (INS) gene region (IDDM2 [MIM 125852]) on
chromosome 11p15. Detailed association mapping us-
ing polymorphic markers spanning this region, as well
as family-based haplotype association studies, indicate
that susceptibility is tightly associated with alleles at a
variable number of tandem repeats (VNTR) marker lo-
cated 596 bp upstream of the start site of transcription
for the INS gene (Bell et al. 1984; Lucassen et al. 1993;
Owerbach and Gabbay 1993, 1994; Julier et al. 1994;
Bennett et al. 1995). Alleles at this VNTR have been
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demonstrated to affect the steady-state level of insulin
mRNA in both the thymus (Pugliese et al. 1997; Vafiadis
et al. 1997) and the pancreatic islets (Bennett et al. 1995;
Kennedy et al. 1995; Vafiadis et al. 1996), providing
plausible mechanisms for the effect of this polymor-
phism on disease susceptibility.
Many other functional candidate genes have been
tested for their association with T1D. Most such studies
have been unreported, and, with the possible exception
of CTLA4 on chromosome 2q33 (IDDM12 [MIM
601388]), no locus has been identified as a likely one
for T1D. Genomewide scans for association are not yet
feasible, owing to the cost of genotyping and the in-
complete knowledge of the polymorphism and haplo-
type content of the 30,000–50,000 genes predicted to
constitute the human genome. Therefore, most recent
attempts to identify T1D genes have focused primarily
on genetic linkage approaches that use affected sib pairs
(ASPs). T1D was the first genetically complex disorder
to be analyzed on a genomewide basis for linkage in
ASPs, and several whole-genome scans have been re-
ported (Davies et al. 1994; Hashimoto et al. 1994; Con-
cannon et al. 1998; Mein et al. 1998). These genome-
wide scans have provided strong evidence of linkage
between IDDM1 and T1D. The relative risk to siblings,
ls, associated with allele sharing at IDDM1 has been
estimated to be 2.5–3.4. Depending on the model se-
lected for interaction between IDDM1 and other loci,
inheritance at IDDM1 may account for as much as half
of the familial clustering of the disease (Risch 1987).
This strong effect of IDDM1 may overshadow the con-
tributions of other loci and may raise the power re-
quirements for studies that seek to identify them. Ap-
proximately 20 additional putative diabetes loci have
been reported, although, in most cases, the aggregate
supporting evidence has not attained a genomewide sig-
nificance level ( ). IDDM3–IDDM135P  2.2# 10
(MIMs 600318, 600319, 600320, 601941, 600321,
600883, 601942, 601208, 601388, and 601318),
IDDM15 (MIM 601666), and IDDM18 (MIM
605598) correspond to regions displaying increased
LOD scores in genomewide scans and/or evidence of
association by transmission/disequilibrium testing (TDT)
(Spielman et al. 1993; Reijonen and Concannon 2001).
The symbols IDDM14 and IDDM16 have been re-
served but not published. IDDM17 (MIM 603266) was
identified in an extended Bedouin pedigreewithmultiple
affected individuals in whom T1D was associated with
HLA-DR3 (Verge et al. 1998). Several other regions that
may harbor susceptibility loci, including 1q42, Xp11,
and 16q22-q24, have also been implicated in genome-
wide scans (Concannon et al. 1998; Cucca et al. 1998;
Mein et al. 1998).
The large number of T1D loci reported, although
promising, also reflects an underlying problem: Studies
from different laboratories have, by and large, yielded
discordant findings. This problem is most clearly illus-
trated by a comparison of the results reported from the
two largest genomewide scans completed in T1D ASPs,
one that included 356 families from the United King-
dom (Mein et al. 1998) and another that analyzed 187
families from the United States, with follow-up of pos-
itive findings in 429 additional families (Concannon et
al. 1998). Apart from human leukocyte antigen (HLA)/
IDDM1, there was no agreement between the positive
results of the two studies. The UK study obtained P !
for chromosomes 11p15 (INS/IDDM2),47.4# 10
10p11, and 16q22-q24; whereas the US study detected
1q42 at . Such samples of 200–400 ASPs4P ! 7.4# 10
have only limited power to detect loci with ls 1.4
(Hauser et al. 1996); therefore, the lack of concordance
in the two studies may have resulted from random sam-
pling differences, given their overall lack of power. If
the INS/IDDM2 odds ratio of 3 is typical of non-HLA
loci (equates to a ls of 1.12), then at least 2,500 ASPs
would be required to obtain convincing evidence of link-
age at reasonable levels of statistical power. In addition,
simulation studies suggest that substantially larger sam-
ple sizes are required to reproduce an initial finding of
linkage when the same criteria for significance are ap-
plied in follow-up as in an initial study (Suarez et al.
1994).
In the current study, a genome scan was performed
on 225 newmultiplex families with T1D. The data from
this genome scan were merged with those from our pre-
vious, independently published studies (Davies et al.
1994; Concannon et al. 1998; Mein et al. 1998) and
were jointly analyzed. Evidence of interaction between
loci was sought by assessing the correlation of family-
specific nonparametric linkage (NPL) scores for all loci
at which there was nominal evidence of linkage. For
HLA, a weighting scheme based on the relative risk
associated with different combinations of HLA haplo-
types was used to condition the linkage data. Finally,
stratified analyses of families ordered by age at onset
were performed. These studies provide a consensus view
of the evidence of linkage to T1D in families whose
DNA samples are currently available from public re-
positories. Suggestive evidence of linkage (P  7.4#
) was observed at seven sites in the genome, with410
linkage in other potential regions conditional on strat-
ification by HLA or age.
Subjects and Methods
Subjects
A total of 767 families were studied. The families were
drawn from the Human Biological Data Interchange
(HBDI) repository ( ) (Lernmark et al. 1990),Np 389
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the Diabetes UK Warren I repository ( ) (BainNp 356
et al. 1990), and the Children’s Hospital of Philadelphia
(CHOP) ( ). All families studied were of whiteNp 22
European ancestry and resided in either the United King-
dom or the United States. Mein et al. (1998) established
criteria for inclusion that required at least one affected
sib with onset of disease at age !17 years and no affected
sib with age at onset 129 years. In the present study,
756 of 767 families met these criteria. In the remaining
11 families, ages at onset were 18–36 years. Only four
of these families were included in genome scans; the
other seven were used only for follow-up studies at se-
lected sites.
In the full collection of 767 families, there were 710
with two affected siblings, 51 with three affected sib-
lings, 1 with four affected siblings, and 2 with five af-
fected siblings; in addition, 3 extended pedigrees from
the HBDI repository had both affected sibs and affected
relative pairs with more distant relationships. In total,
there were 831 pairwise independent ASPs, 8 avuncular
pairs, and 4 first-cousin pairs.
Genotyping
Genotypes were derived from three sources. For the
present report, 225 families from the HBDI repository
were genome-scanned at 10-cM resolution by the Mam-
malian Genotyping Service at the Marshfield Institute.
These data, which are reported here for the first time,
were merged with data from our previous genome scans
of 187 families (101 from Warren I, 64 from HBDI, and
22 from CHOP) (Concannon et al. 1998) and a further
356 families from Warren I (Mein et al. 1998). There
was no overlap between the 225 HBDI families who
underwent genome scanning for the present study and
those similarly analyzed in the two previously published
studies. The studies by Concannon et al. (1998) and
Mein et al. (1998) had 100Warren I families in common.
When this overlap is taken into account, the total num-
ber of families in the current analysis that have under-
gone genomewide scanning is 667 (356 Warren I, 289
HBDI, and 22 CHOP). Data from an additional 100
HBDI families genotyped only within selected candidate
regions were also incorporated. Genotype data from all
sources were merged into a single database. Discrep-
ancies in family-naming conventions were resolved. In-
dividual marker names were modified to indicate the
laboratory of origin for the genotyping; no markers were
deleted. There was ∼20% overlap in marker usage
among the three merged data sets. Markers that over-
lapped between the different data sets were given distinct
designations and were treated as unique markers spaced
0.1 cM apart.
Analyses
The complete data set was screened for Mendelian
inconsistencies, using PedCheck (O’Connell and Weeks
1998). Inconsistencies were eliminated by retyping or by
removal from the analysis. Multipoint linkage analysis
was performed using the S (pairs) option of GeneHunter-
Plus, and maximized LOD scores were calculated under
an exponential model with d constrained between 0 and
2 (Kong and Cox 1997).
To search for evidence of statistical interaction be-
tween unlinked loci (Cox et al. 1999), correlations were
calculated using family-specific NPL scores for loci yield-
ing nominal evidence of linkage to T1D (LOD 0.59;
). This analysis was performed in two stages, fo-P ! .05
cusing first on those loci where the evidence of linkage
was suggestive (LOD 2.2) and then on all loci with
LOD 0.59. P values were calculated from a t statistic
with 766 df and corrected, by the Bonferroni method,
for the number correlations examined. This test is
slightly conservative, because the number of compari-
sons for different loci varied but was always less than
the total number of families used to set the degrees of
freedom.
In the specific case of IDDM1 (HLA), family-specific
weights were assigned on the basis of the degree of risk
associated with the HLA-DR and -DQ genotypes of the
affected members of each pedigree. Families received
weights on a scale of 1.0–5.0, with 5.0 corresponding
to the highest HLA-encoded risk (families in which all
affected individuals had the high-risk genotype combi-
nation DR3 and DR4) and 1.0 corresponding to the
lowest risk (no affected individuals with either DR3 or
DR4). Intermediate risks were assigned on the basis of
the mixture of DR3, DR4, and DRX (where “X” is not
3 or 4) present in the affected members of the pedigrees.
DR4 haplotypes carrying the DQB1*0301 allele were
treated as lower risk than those with the DQB1*0302
allele. A total of 453 families in the data set had geno-
types for DR and DQ available. To establish a baseline
for conditional analyses, these families were assigned
weight 1, all other families were assigned weight 0, and
LOD scores were calculated. Multipoint analyses were
then performed in subsets of families defined by HLA
risk, by assigning weight 1 to the families in which geno-
types for DR and DQ were available and assigning
weight 0 to all others.
As an initial screen for significance in these conditional
analyses, all sites were identified where conditioning re-
sulted in an increase 1.44 in the LOD score over that
obtained in the baseline analysis. The increase over base-
line LOD score obtained by family weighting multiplied
by 2ln(10) is asymptotically distributed as a x2 with 1
df, under the null hypothesis of no interaction. When
this test is used, a cutoff of 1.44 corresponds to a P value
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of .01. Although appropriate as a screening tool, this
test does not take into account the possibility of false
positives resulting from multiple testing, nor does it
consider that there are different proportions of fam-
ilies in the different weighted subsets. Therefore, the
significance of any observed increase in the LOD score
at specific chromosomal positions was assessed by
simulations in which families were randomly assigned
to have weight 1 or weight 0, with the number of
families of each type determined by the actual number
of families assigned weights 1 and 0 for that HLA-
based analysis. All simulations included at least 1,000
replicates. For the region on chromosome 10p13,
10,000 replicates were analyzed.
For age-at-onset analyses, families were ranked on the
basis of the oldest affected sibling’s age at onset. Ex-
tended pedigrees with more-distant relative pairs and
families with incomplete age-at-onset information were
excluded by assigning them weight 0 in all analyses. This
excluded group accounted for 85 of the overall pool of
767 families. Among the remaining 682 families, there
was no significant difference between the mean age at
onset in first, second, or third affected siblings (11.1,
11.0, and 11.2 years, respectively). Genomewide anal-
ysis was performed with only a single weighting scheme
that assigned weight 1 to families in which both affected
sibs had onset at age 11 years and assigned weight 0
to all other families.
Power Calculations
Calculations of the power of this collection of families
to detect linkage were done assuming a fully informative
marker locus with no recombination to the disease-sus-
ceptibility locus, using a formula derived from Gu and
Rao (1997).
Results
Multipoint Linkage Analyses
The current study incorporates genotype data from a
total of 767 multiplex families with T1D: 356 UK fam-
ilies from the Diabetes UK Warren I repository and 411
US families from the HBDI repository and CHOP. The
US families include 225 families that were newly geno-
typed at 10-cM resolution specifically for this report.
The total of 767 families presented here (667 with ge-
nomewide-scan data) constitutes a substantial increase
over the largest collection of families with T1D studied
for linkage to date. Figure 1 shows the results of mul-
tipoint linkage analysis in this data set.
There were seven sites at which the multipoint evi-
dence of linkage was either suggestive (LOD 2.2;
) or significant (LOD 3.6;4P  7.4# 10 P  2.2#
), according to previously proposed criteria (Lander510
and Kruglyak 1995). As expected, the contribution of
the IDDM1 region was easily detected ( ).LODp 65.8
The IDDM2 region also showed significant evidence of
linkage ( ). To exclude possible bias in theLODp 4.28
detection of IDDM2 resulting from the inclusion of
markers selected for their reported allelic association
with T1D, a second analysis of the data for chromosome
11 was performed with these markers excluded. When
data for only the framework markers D11S922 and
D11S2362 flanking the region were included, the max-
imum multipoint LOD score in the IDDM2 region was
still suggestive of linkage ( ).LODp 2.53
One additional region on 16q, near the marker
D16S3098, also displayed significant evidence of linkage
( ). Mein et al. (1998) have reported sug-LODp 3.93
gestive evidence of linkage to this same region, and Cor-
dell et al. (1995) suggested, on the basis of a two-locus
conditional analysis, the possibility of interaction be-
tween this locus and IDDM1. Additional genotyping of
the marker D16S3098 was performed in families col-
lected by HBDI, and this resulted in a further increase
in the LOD score to 4.13.
Suggestive evidence of linkage was observed at four
additional sites. On chromosome 10p11, near the
marker D10S565, a LOD score of 2.80 was obtained.
The position of this site corresponds approximately to
that of the putative IDDM10 locus (Reed et al. 1997;
Mein et al. 1998). On chromosome 2q, three putative
loci, IDDM7 (2q31, D2S152 associated), IDDM12
(2q33, CTLA4 associated) and IDDM13 (2q34-q34,
NRAMP1 associated), have been described elsewhere
(Copeman et al. 1995; Morahan et al. 1996; Nistico et
al. 1996; Esposito et al. 1998). A single peak was ap-
parent on chromosome 2q31, near themarkerD2S1391,
with a maximum LOD of 2.62. On chromosome 6q, a
LOD score of 2.36 was observed, corresponding to the
putative locus IDDM15 (Delepine et al. 1997). Caution
is required in the interpretation of these results for
IDDM15, because of the potential confounding effects
of the strong sharing at IDDM1. Finally, on chromo-
some 1q, there were two closely spaced peaks
( ) that corresponded to the previously re-LODp 2.2
ported linkage at 1q42 (Concannon et al. 1998).
There were five other chromosome regions where the
multipoint LOD was 11.5. In addition to the peaks at
IDDM1 and IDDM15, there were two peaks on 6q,
with LOD scores of 1.96 and 1.81, that may correspond
to the loci reported elsewhere: IDDM5 (Davies et al.
1994) and IDDM8 (Luo et al. 1995). Other peaks oc-
curred on chromosomes 16p11-p13 ( ),LODp 1.74
17q25 ( ), and 19q11 ( ).LODp 1.81 LODp 1.80
Testing for Interaction between Unlinked Loci
Analytic methods that take into account the joint ef-
fects that multiple genetic loci have on risk may
Figure 1 Multipoint linkage analysis, using GeneHunter-Plus, in merged T1D data set. LOD scores were calculated using ASM under an
exponential model, with d constrained between 0 and 2. LOD scores are plotted against chromosomal position (in cM).
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Table 1
Interaction between NPL Scores in Unlinked Regions
FIRST LOCUS IN PAIR SECOND LOCUS IN PAIR
CORRELATION PChromosome Position Chromosome Position
13 14.60 19 .10 .10129 .005
2 84.40 11 7.90 .09978 .006
6 160.90 10 124.20 .09756 .007
1 54.70 2 84.40 .09663 .007
1 144.50 19 .10 .09436 .009
2 84.40 14 50.10 .09016 .012
4 5.60 6 160.90 .09012 .012
1 260.60 11 7.90 .08653 .016
1 266.70 11 7.90 .08186 .023
3 94.80 6 160.90 .08141 .024
1 54.70 6 160.90 .07792 .031
6 179.10 10 124.20 .07554 .036
1 127.30 6 193.00 .07540 .037
2 256.80 11 70.50 .07440 .039
4 5.60 6 147.60 .07342 .042
6 147.60 14 141.30 .07318 .043
11 70.50 19 .10 .07275 .044
3 94.80 6 147.60 .07149 .048
1 54.70 1 144.50 .07110 .049
2 256.80 16 101.10 .07096 .049
6 179.10 11 7.90 .07259 .044
2 256.80 16 48.00 .07456 .039
6 193.00 11 7.90 .07553 .036
strengthen the evidence of their existence and contribute
to their localization. Evidence of statistical interactions
between unlinked loci in the present study was evaluated
by calculating correlations between family-specific NPL
scores for pairs of loci in a two-step process (Cox et al.
1999). Initially, calculations were performed only for
pairs of loci, excluding IDDM1, that displayed evidence
of linkage ( ) in the overall genome scan.4P  7.4# 10
A total of 15 correlations were calculated using NPL
scores at the regional multipoint maximums correspond-
ing to IDDM2, IDDM15, 16q22-q24, IDDM10,
IDDM7, and 1q42. A single position at 1q42 was cho-
sen, because the two peaks had equivalent LOD scores,
and the NPL scores at the two sites were highly corre-
lated ( ; ). The number of families con-rp .92 P ! .0001
sidered in each calculation was 727–747. Only one cor-
relation (1q42 with IDDM2) was nominally significant
( ), but not after correction for the number of testsP ! .05
performed.
The testing of loci that individually display substantial
evidence of linkage to T1D is useful as a means of mod-
eling interactions between established susceptibility loci.
However, there may be additional loci that do not in-
dividually provide significant evidence of linkage but
that may be revealed on the basis of evidence of their
interaction. Accordingly, the screen for correlation be-
tween family-specific NPL scores was broadened, in a
second stage, to include all possible pairs of unlinked
loci that displayed nominal evidence of linkage in the
overall genome scan ( ; LOD  0.59), again withP ! .05
the exception of IDDM1. A total of 422 pairs of loci
were examined, 23 of which yielded results that were
nominally significant ( ) (table 1), but again, noneP ! .05
remained so after correction for multiple testing.
Conditioning on HLA Genotypes
To perform subgroup analyses based on HLA geno-
types, the linkage data from individual families were
weighted on the basis of the risk associated with the
HLA-DR and -DQ genotypes present in the individual
affected members. By applying weight 1 or weight 0 to
specific categories of families, it was then possible to
recalculate LOD scores, after the basic GeneHunter anal-
ysis was completed, to model various types of interac-
tions. Initially, a baseline analysis was performed in
which weight 1 was assigned to all families ( )Np 453
for which complete HLA-DR and -DQ genotyping in-
formation was available, and weight 0 was assigned to
all other families. Three different weighting schemes
based on the possible contributions of HLA to T1D sus-
ceptibility were then applied. To model positive inter-
actions, weight 1 was assigned to families in which every
affected individual carried the DR3/DR4 genotype that
confers the highest HLA-encoded risk ( ), andNp 159
weight 0 was assigned to all other families. As a model
for heterogeneity, conditional analyses were performed
in which weight 1 was assigned to families in which no
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Figure 2 Multipoint analysis of linkage to T1D on chromosome
10, conditioning on HLA. LOD scores are plotted against chromo-
somal position in centimorgans. Solid line indicates the baseline LOD
score in all families for which HLA-typing data were available
( ). Dotted line indicates LOD score in families in which allNp 453
ASPs were HLA-DR3/DR4 heterozygotes ( ). Dashed line in-Np 159
dicates LOD score in families for which HLA-typing data were avail-
able, excluding families in which all ASPs were HLA-DR3/DR4 het-
erozygotes ( ).Np 294
affected member had DR3 or DR4 haplotype (Np
), and weight 0 was assigned to all other families.19
Finally, we focused on families with DR3-encoded risk
of diabetes only as suggested by previous studies (Cucca
et al. 1998; Verge et al. 1998). Families were assigned
weight 1 if all affected members had at least one DR3
haplotype and no affected member had a DR4 haplotype
( ), with all other families receiving weight 0.Np 62
There were two sites where these conditional analyses
resulted in an increase above the baseline LOD score
that was significant at . On chromosome 3 atP  .01
94.8 cM (3p12-q13), the baseline LOD was 0.41, and
the LOD score at this position in families in which the
affected members had DR3, but not DR4, was 1.95
( ). The second site was located on chromosomePp .005
10p13, where an increase in LOD score was observed
in the subset of families in which all affected individuals
had the high-risk DR3/DR4 genotype. This increase in
LOD score, from a baseline value of 1.38 to 3.66, was
the most significant pointwise increase observed in the
conditional analyses overall ( ) (fig. 2). How-Pp .0007
ever, it occurs within 23 cM of the peak (described
above) that we observed in the overall linkage analysis
at 10p11 ( ), raising the possibility that theseLODp 2.8
two findings represent a single linked region. An addi-
tional analysis, in which families with DR3/DR4 hap-
lotype were given weight 0, suggests that the evidence
of linkage at 10p13 and 10p11 derives from largely non-
overlapping sets of families (fig. 2). No significant in-
crease in LOD score was observed at this site in a specific
follow-up analysis in which families were assigned
weights according to the presence of individual DR3 or
DR4 haplotypes.
The effects of these conditioning schemes were ex-
amined specifically at previously reported T1D suscep-
tibility loci. In only one case was an increase above the
baseline LOD score observed that was nominally sig-
nificant. This occurred in the region of the IDDM17
locus, where the baseline LOD was 1.56 but increased
to 2.44 in the subset of 62 families in which all affected
individuals had a DR3 haplotype and none had DR4
( ).Pp .027
The subset in which no affected individual had either
of the T1D-associated HLA haplotypes (DR3 or DR4)
contained only 19 families. This sample is so small that
it is not clear there is merit in comparing results from
this subset with results from the baseline analyses. Over-
all, no chromosome region displayed a LOD score 12.0
in this subset.
Age-at-Onset Subgroup Analysis
As in the case of HLA, testing for an effect of age at
onset on the evidence of linkage in families is compli-
cated by the fact that, although age at onset is a char-
acteristic of a single individual, linkage is inherently a
characteristic of groups. To take into account both in-
dividual age at onset and ASP concordance for this phe-
notype, families were classified according to the latest
age at onset in any affected sibling. A genomewide search
for linkage to T1D, conditioning on early age at onset,
was performed by assigning weight 1 to families inwhich
all affected siblings had onset of disease at an age less
than or equal to the mean age at onset for the entire
collection and by assigning weight 0 to all other families.
Only one site in the genome displayed a significant in-
crease in LOD score in this subset of 287 families, com-
pared with the baseline LOD determined for 682 fam-
ilies. On chromosome 6q27, the baseline LOD score was
0.94, and the conditional LODwas 3.69 ( ) (fig.Pp .003
3). This peak in the conditional analysis may correspond
to the IDDM8 locus reported elsewhere (Davies et al.
1994; Luo et al. 1995; Owerbach 2000). Increases above
the baseline LOD score at this point were also observed
when families were selected for increasingly early ages
at onset in ASPs, for example, age 8 years ( ;Np 154
) or age 5 years ( ; ).LODp 2.56 Np 79 LODp 1.42
Discussion
Extensive study of the genetics of T1D, during the last
three decades, has resulted in the mapping of numerous
putative susceptibility loci (Reijonen and Concannon
2001). Despite these efforts, and the considerable en-
thusiasm with which genome-scanning approaches in
ASPs have been applied since 1994, progress toward
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Figure 3 Multipoint analysis of linkage to T1D on chromosome
6, conditioning on age at onset. LOD scores are plotted against chro-
mosomal position in centimorgans. Solid line indicates the baseline
LOD score in all families for which age-at-onset data were available
( ). Dashed line indicates LOD score in families in which allNp 682
affected siblings had onset of disease at age 11 years ( ).Np 287
identification of the underlying susceptibility genes for
T1D has been slow. The most likely explanation for this
limited progress is that no locus, except HLA/IDDM1,
appears to have a ls 11.4, at least in the general pop-
ulations of the United Kingdom and the United States.
Two collections of DNA samples from families with T1D
are publicly available for genetic linkage studies, the Di-
abetes UK Warren 1 repository of samples from the
United Kingdom and the HBDI collection of samples
largely from the United States. Each collection contains
!500 ASPs and is independently capable of providing
power to detect loci with a ls 11.5; however, each has
only modest power to detect effects in the ls range of
1.1–1.4. Nonetheless, putative diabetes loci IDDM3-13,
IDDM15, IDDM17, and IDDM18, as well as un-
named regions on chromosomes 1q42, 16q22-24, and
Xp11, have been reported. The loci have been iden-
tified on the basis of linkage data and, in some cases,
on evidence of association (e.g., CTLA4/IDDM12 and
IL12B/IDDM18). None of these regions has been in-
dependently confirmed in a fully convincing way,
mainly owing to the lack of additional, independent
families.
In this report we have combined the UK and US data
sets and incorporated new genomewide-scan data from
225 additional multiplex families, yielding a total of
767 families and 831 pairwise ASPs. The resulting
merged data set is significantly larger than any collection
previously analyzed for T1D linkage and could be ex-
pected to provide at least 80% power to detect sug-
gestive evidence of linkage ( ) for loci4Pp 7.4# 10
with ls1.3 and to provide significant evidence of link-
age ( ) for loci with ls 1.4. Linkage at
5Pp 2.2# 10
IDDM1 was easily detected in this data set, as it was
in smaller data sets (Davies et al. 1994). Our detection
of linkage at six non-HLA regions at a level of signif-
icance ( ) for which approximately one4P ! 7.4# 10
observation would be expected by chance alone indi-
cates the presence of additional T1D loci. Overall, the
probability of obtaining five loci, each with P ! 7.4#
, is .004. Confirmation of these and other, as yet410
undetected, loci will require a much larger number of
families, at least 2,500 ASPs, to detect loci with odds
ratios of 2.5–3.0, as is the case for INS/IDDM2. The
odds ratio of 2.5–3.0 for the INS VNTR class I allele
homozygous genotype corresponds to ls of 1.12. Al-
though the present study analyzed data from !2,500
ASPs, a LOD score of 4.28 was obtained in the IDDM2
region. There are several possible explanations for this
result. It may be a chance event, given that our study
sample contained only 831 ASPs. It may also indicate
that the IDDM2 region on chromosome 11p15 contains
additional T1D loci. A third possibility is that the sig-
nificance of the evidence of linkage in this region reflects,
in part, the presence of linkage disequilibrium with sev-
eral of the markers that were genotyped because of their
proximity to INS. Consistent with this possibility, a sub-
stantial decrease in LOD score (from 4.28 to 2.53) in
this region was observed when only framework micro-
satellite markers were used in the analysis, even though
the INS-specific markers that were excluded were of
only modest information content.
Previous studies have stratified on allele sharing at
HLA-DRB1 or -DQB1 as a means of revealing addi-
tional loci whose effects might be more easily discerned
on the basis of their interaction with IDDM1. However,
allele sharing at DRB1 or DQB1 may not be a very
powerful parameter to condition on in T1D, given (a)
the high percentage of ASPs that share alleles at IDDM1
and (b) the fact that many parents in multiplex families
carry two susceptible HLA class II haplotypes. A pre-
vious study of the HBDI collection of multiplex families
with T1D revealed that the majority of ASPs that did
not share parental alleles at HLA nevertheless had high-
risk genotypes (Noble et al. 1996). Therefore, to test
for possible interactions between specific HLA geno-
types and allele sharing at non-HLA loci, we con-
structed a weighting scheme based on the risks associ-
ated with specific genotypes atDRB1 andDQB1. Given
the considerations with regard to power that are dis-
cussed and cited above, these analyses, which involve
limited subsets of our collection of families, have only
modest power and should be considered exploratory.
Two results obtained by conditioning on HLA, both
on chromosome 10, are noteworthy. On chromosome
10p13, a LOD of 3.66 was obtained in the subset of
159 families in which all affected individuals had the
high-risk DR3/DR4 genotype. The increase, relative to
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baseline, in the LOD score at this position was signif-
icant and was specific to the DR3/DR4 combination
( , when tested by simulation in a pointwisePp .0007
test). Evidence of linkage at 10p13 ( in theLODp 3.66
conditional analysis) and the adjacent 10p11 interval
( in the overall analysis) came from largelyLODp 2.80
nonoverlapping sets of families. We recognize that,
given the overall evidence of linkage at 10p11, there is
considerable likelihood that the localization and mag-
nitude of that signal may drift in randomly chosen sub-
sets of the data. Further studies in larger collections of
families will be necessary to clarify whether there is a
single locus or multiple loci in this region.
At chromosome 10q25, increased LOD scores were
observed near the reported location of the putative
IDDM17 locus. Although the increase over baseline
LOD at this site was only nominally significant, the
location of the increase—and its occurrence in the sub-
set of families in which all affected individuals have
DR3 and none has DR4—is consistent with the original
description of IDDM17. The result raises the possibility
that this locus, originally identified in a single large ped-
igree, may have a measurable effect in the general pop-
ulations of the United Kingdom and the United States,
which might help in the fine-mapping of the locus.
Lernmark and Ott (1998) suggested that differences
in the findings in the genome scans of Concannon et al.
(1998) and Mein et al. (1998) might have resulted from
the application of specific age-at-onset criteria in the
latter study. However, in merging the data from these
two previous studies, we encountered only 11 (of 767)
families that did not meet these age-at-onset criteria.
Nevertheless, conditioning on age at onset may identify
more genetically homogeneous subsets of families or
one in which the role of environmental factors in sus-
ceptibility is reduced. We explored this possibility by
focusing on the evidence of linkage in the subset of
families in which both affected siblings had early onset
of disease, as suggested by Li and Hsu (2000). Signifi-
cantly increased LOD scores were observed at only one
site in this subset, at chromosome 6q27. Linkage and
association studies have mapped the IDDM8 locus to
this same general region (Davies et al. 1994; Luo et al.
1995; Owerbach 2000), but it is not clear whether the
increased LOD scores that we observed in the present
conditional analysis correspond exactly to the IDDM8
locus defined in previous studies. Subsets of families
with incrementally lower ages at onset for ASPs, also
showed increased LOD scores over baseline at this site.
A similar approach, focusing on transmissions to af-
fected offspring with earlier ages at onset in a TDT
analysis (Li andHsu 2000), might aid in linkage disequi-
librium mapping in the region.
In the present study, we used several analytic ap-
proaches to try to identify and/or clarify the contribu-
tions of loci to T1D susceptibility. However, the most
effective strategy employed was also the simplest and
most obvious: increasing the sample size. This was ac-
complished, in part, by performing a new genome scan,
but the majority of the data analyzed came from the
merging of information obtained from previous studies.
Given the number of families that have already been
studied worldwide for linkage to T1D—either in fo-
cused, site-specific studies or in genomewide scans—the
most expedient approach to further progress in the iden-
tification of genes for T1D would be through the efforts
of a consortium to merge and jointly analyze all extant
data sets for linkage. In the meantime, the present study
provides the best evidence yet for a role of multiple non-
HLA genes in the familial clustering of T1D in humans,
as has been previously demonstrated in spontaneous
rodent models of T1D.
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